These findings suggest that targeting Opa1 or more generally mitochondrial dynamics could provide new therapeutic tools against endothelial disorders which are involved in a handful of cardiovascular and cerebrovascular diseases. This evidence concerns the gene OPA1 and cerebrovascular disorder.